This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Proprietary Semaglutide + Tirzepatide Dual-Peptide Formulation Now Available Exclusively Through the Tru2u.health PlatformLake Oswego, Portland--(Newsfile Corp. - May 6, 2026) - Functional Brands Inc.

Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...

Researchers conducted a phase 3 trial to compare the efficacy and safety of synthetic semaglutide with Ozempic® for glycemic ...

Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what’s the difference? And which form is more effective for weight loss? Semaglutide ...

You can inject Wegovy (semaglutide) under the skin of your lower abdomen, upper arm, or upper thigh, rotating the injection site each week. Do not inject Wegovy into a vein or muscle. To ensure the ...

In the ever-evolving landscape of weight management and diabetes treatment, semaglutide has emerged as a significant player. Originally approved by the FDA for managing type 2 diabetes under Ozempic, ...

India's injectable GLP-1 therapy market has expanded tenfold in a year, with generic semaglutide adding fresh momentum. Even ...

Today, Health Canada authorized a generic semaglutide injection. This is the first generic semaglutide authorized by Health Canada, and the first to be approved in the G7. Health Canada is currently ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and ...

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...